Pediatrix Medical Group (MD) Scheduled to Post Quarterly Earnings on Friday

Pediatrix Medical Group (NYSE:MD) is set to post its quarterly earnings results before the market opens on Friday, November 1st. Analysts expect the company to announce earnings of $0.35 per share for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

Pediatrix Medical Group (NYSE:MD) last posted its earnings results on Tuesday, August 6th. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.03. Pediatrix Medical Group had a negative net margin of 12.58% and a positive return on equity of 10.59%. The firm had revenue of $504.30 million for the quarter, compared to analysts’ expectations of $505.49 million. During the same quarter in the previous year, the firm posted $0.37 earnings per share. The company’s revenue was up .7% on a year-over-year basis. On average, analysts expect Pediatrix Medical Group to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Pediatrix Medical Group Stock Up 0.9 %

Shares of MD opened at $12.97 on Wednesday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.38 and a current ratio of 1.38. Pediatrix Medical Group has a 52 week low of $6.62 and a 52 week high of $13.02. The stock has a market capitalization of $1.11 billion, a price-to-earnings ratio of -4.28, a PEG ratio of 1.92 and a beta of 1.56. The stock has a fifty day moving average of $11.48 and a 200-day moving average of $9.32.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on MD. Jefferies Financial Group upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating and boosted their price target for the stock from $8.00 to $14.00 in a report on Thursday, September 26th. UBS Group boosted their target price on shares of Pediatrix Medical Group from $9.00 to $10.50 and gave the stock a “neutral” rating in a report on Friday, August 9th. Truist Financial raised their price target on shares of Pediatrix Medical Group from $10.00 to $13.00 and gave the company a “hold” rating in a research note on Monday, October 7th. Finally, StockNews.com upgraded Pediatrix Medical Group from a “sell” rating to a “hold” rating in a report on Wednesday, August 7th. Five equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, Pediatrix Medical Group has an average rating of “Hold” and a consensus price target of $10.90.

Insider Activity

In other Pediatrix Medical Group news, CFO C Marc Richards sold 32,562 shares of the company’s stock in a transaction on Friday, August 9th. The shares were sold at an average price of $10.08, for a total transaction of $328,224.96. Following the sale, the chief financial officer now owns 192,785 shares of the company’s stock, valued at approximately $1,943,272.80. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, CEO James D. Swift sold 11,100 shares of Pediatrix Medical Group stock in a transaction on Friday, August 30th. The shares were sold at an average price of $10.79, for a total value of $119,769.00. Following the completion of the sale, the chief executive officer now owns 170,001 shares in the company, valued at $1,834,310.79. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO C Marc Richards sold 32,562 shares of the firm’s stock in a transaction on Friday, August 9th. The stock was sold at an average price of $10.08, for a total transaction of $328,224.96. Following the completion of the sale, the chief financial officer now owns 192,785 shares of the company’s stock, valued at $1,943,272.80. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 68,100 shares of company stock valued at $701,889. 1.20% of the stock is currently owned by insiders.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.